Effect of previous interferon treatment on the recurrence of hepatocellular carcinoma in patients with hepatitis C

被引:0
|
作者
Miyatake, Hirokazu
Kobayashi, Yoshiyuki
Iwasaki, Yoshiaki
Nakamura, Shinichirou
Tanaka, Hironori
Miyake, Yasuhiro
Terada, Ryo
Miyoshi, Kenji
Ohnishi, Hideki
Iwadou, Shouta
Shouji, Bon
Kuwaki, Takeshi
Sakaguchi, Kohsaku
Shiratori, Yasushi
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A497 / A497
页数:1
相关论文
共 50 条
  • [1] Sustained virologic response to previous interferon treatment may reduce the risk for the recurrence of hepatocellular carcinoma in patients with hepatitis C
    Miyatake, Hirokazu
    Kobayashi, Yoshiyuki
    Iwasaki, Yoshiaki
    Nakamura, Shinichiro
    Terada, Ryo
    Miyoshi, Kenji
    Ohnishi, Hideki
    Iwadou, Shouta
    Shoji, Bon
    Kuwaki, Kenji
    Toshimori, Junichi
    Yasunaka, Tetsuya
    Hagihara, Hiroaki
    Sakaguchi, Kohsaku
    GASTROENTEROLOGY, 2007, 132 (04) : A202 - A202
  • [2] Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma
    Saito, Tomoko
    Chiba, Tetsuhiro
    Suzuki, Eiichiro
    Shinozaki, Masami
    Goto, Nobuaki
    Kanogawa, Naoya
    Motoyama, Tenyu
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Tawada, Akinobu
    Kanda, Tatsuo
    Miyazaki, Masaru
    Yokosuka, Osamu
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, 11 (07): : 707 - 712
  • [3] Effect of Previous Interferon Treatment on Outcome After Curative Treatment for Hepatitis C Virus-Related Hepatocellular Carcinoma
    Miyatake, Hirokazu
    Kobayashi, Yoshiyuki
    Iwasaki, Yoshiaki
    Nakamura, Shin-ichiro
    Ohnishi, Hideki
    Kuwaki, Kenji
    Toshimori, Junichi
    Hagihara, Hiroaki
    Nouso, Kazuhiro
    Yamamoto, Kazuhide
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) : 1092 - 1101
  • [4] Effect of Previous Interferon Treatment on Outcome After Curative Treatment for Hepatitis C Virus-Related Hepatocellular Carcinoma
    Hirokazu Miyatake
    Yoshiyuki Kobayashi
    Yoshiaki Iwasaki
    Shin-ichiro Nakamura
    Hideki Ohnishi
    Kenji Kuwaki
    Junichi Toshimori
    Hiroaki Hagihara
    Kazuhiro Nouso
    Kazuhide Yamamoto
    Digestive Diseases and Sciences, 2012, 57 : 1092 - 1101
  • [5] Effect of interferon on incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Soga, K
    Shibasaki, K
    Aoyagi, Y
    HEPATO-GASTROENTEROLOGY, 2005, 52 (64) : 1154 - 1158
  • [6] Influence of previous interferon therapy on recurrence after resection of hepatitis C virus-related hepatocellular carcinoma
    Kubo, S
    Nishiguchi, S
    Hirohashi, K
    Tanaka, H
    Tsukamoto, T
    Shuto, T
    Takemura, S
    Yamamoto, T
    Ikebe, T
    Wakasa, K
    Shiomi, S
    Kinoshita, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (01): : 59 - 66
  • [7] The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment
    Miyajima, I
    Sata, M
    Kumashiro, R
    Uchimura, Y
    Ide, T
    Suzuki, H
    Tanikawa, K
    ONCOLOGY REPORTS, 1998, 5 (01) : 201 - 204
  • [8] Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma
    Uenishi, T
    Kubo, S
    Hirohashi, K
    Tanaka, H
    Shuto, T
    Yamamoto, T
    Tamori, A
    Hai, S
    Kinoshita, H
    Nishiguchi, S
    HEPATOLOGY RESEARCH, 2002, 24 (04) : 404 - 412
  • [9] Effect of interferon on the progression to hepatocellular carcinoma in chronic hepatitis C Egyptian patients
    ElKhayat, HR
    Omar, MM
    Yehia, HA
    Moustafa, I
    HEPATOLOGY, 1997, 26 (04) : 1498 - 1498
  • [10] Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
    Hiroaki Hagihara
    Kazuhiro Nouso
    Yoshiyuki Kobayashi
    Yoshiaki Iwasaki
    Shinichiro Nakamura
    Kenji Kuwaki
    Junichi Toshimori
    Hirokazu Miyatake
    Hideki Ohnishi
    Hidenori Shiraha
    Kazuhide Yamamoto
    International Journal of Clinical Oncology, 2011, 16 : 210 - 220